Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Metastatic Hormone-sensitive Prostate Cancer (mHSPC) × darolutamide × 30 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 9 Prostatic Diseases 2 Neoplasms 2 Male Urogenital Diseases 2 Bulbo-Spinal Atrophy, X-Linked 2 Urogenital Neoplasms 1 Urogenital Diseases 1 Salivary Gland Neoplasms 1 Prostatic Neoplasms, Castration-Resistant 1 Prostate Adenocarcinoma 1 Non-metastatic Castration-resistant Prostate Cancer 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Metastatic Castration-resistant Prostate Neoplasms 1 Metastatic Castration-resistant Prostate Cancer 1 High-Risk Localized Prostate Cancer 1 Granulosa cell tumor of the ovary 1 Genital Diseases, Male 1 Biochemically Recurrent Prostate Cancer 1 Advanced Solid Tumor 1 Adenocarcinoma 1

Interventions

niraparib 1 Prednisone 1 Docetaxel 1 Androgen Antagonists 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡